BTAI - BioXcel Therapeutics Inc
IEX Last Trade
0.6191
-0.016 -2.601%
Share volume: 202,394
Last Updated: Fri 30 Aug 2024 09:59:31 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.64
-0.02
-2.54%
Summary score
30%
Profitability
25%
Dept financing
22%
Liquidity
59%
Performance
30%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-66.48%
Return on assets
-20.74%
Return on sales
-15626.21%
Return on invested capital
200.54%
Total debt ratio
55.43%
Debt ratio change over timeo
-0.55%
Current Ratio
10.41%
Quick Ratio
10.79%
Cash Position Ratio
10.11%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-177.97%
Return on assets
-34.42%
Return on sales
-8462.19%
Return on invested capital
118.08%
Total debt ratio
150.2%
Debt ratio change over timeo
0.43%
Current Ratio
2.93%
Quick Ratio
2.86%
Cash Position Ratio
2.68%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
37.02%
Return on assets
-29.35%
Return on sales
-4151.72%
Return on invested capital
89.08%
Total debt ratio
187.9%
Debt ratio change over time
1.17%
Current Ratio
2.57%
Quick Ratio
2.49%
Cash Position Ratio
2.36%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-132.04%
Return on assets
-113.48%
Return on sales
-9881.16%
Return on invested capital
1.91%
Total debt ratio
-54.67%
Debt ratio change over time
-0.55%
Current Ratio
3.84%
Quick Ratio
3.94%
Cash Position Ratio
3.67%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | BTAI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -66.48% | 13.79% | 34.47% | 7.43% |
| Return on assets | -20.74% | 2.76% | 3.15% | 5.62% |
| Return on sales | -15626.21% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 200.54% | 2.36% | 5.39% | 19.77% |
| Profitability | 25% | 40% | 60% | 58% |
| Total debt ratio | 55.43% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.55% | 308.97% | -6.99% | 1.18% |
| Dept financing | 15% | 50% | 25% | 7% |
| Current Ratio | 2.93% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.86% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.68% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 5% | 11% | 24% |
| Short-term ratios | BTAI | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -177.97% | 13.77% | 13.25% | 3.8% |
| Return on assets | -34.42% | 2.43% | 1.89% | 3.09% |
| Return on sales | -8462.19% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 118.08% | 2.14% | 3.39% | 9.18% |
| Profitability | 25% | 65% | 60% | 59% |
| Total debt ratio | 150.2% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | 0.43% | 46.38% | -72.08% | 1.51% |
| Dept financing | 25% | 40% | 15% | 4% |
| Current Ratio | 2.93% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 2.86% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.68% | 0.36% | 1.28% | 2.93% |
| Liquididy | 52% | 12% | 31% | 75% |